Zhoufeng Wang

Zhoufeng Wang


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Journal of Electroanalytical Chemistry
Verified
Journal Article
Closed access
ZWZhoufeng Wang
Zhoufeng Wang
FLFang Liao
Fang Liao
TGTingting Guo
Tingting Guo
SYSiwei Yang
Siwei Yang
CZChunmei Zeng
Chunmei Zeng

21 May 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
JYJianhong Yang
Jianhong Yang
YYYamei Yu
Yamei Yu
YLYong Li
Yong Li
WYWei Yan
Wei Yan
HYHaoyu Ye
Haoyu Ye
LCLijuan Chen
Lijuan Chen
A novel binding site on α-tubulin shows promise as a target for a new generation of anticancer drugs.

17 July 2018 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
WLWenxin Luo
Wenxin Luo
ZWZhoufeng Wang
Zhoufeng Wang
PTPanwen Tian
Panwen Tian
WLWeimin Li
Weimin Li

4 January 2023 in Frontiers in Public Health
Verified
Journal Article
Open access
QZQin Zhang
Qin Zhang
XTXiumei Tang
Xiumei Tang
YZYanjie Zhao
Yanjie Zhao
ZWZhoufeng Wang
Zhoufeng Wang
Introduction: Our study aims to identify, appraise, and summarize randomized controlled trials (RCT) on the effectiveness of team-based learning (TBL) versus lecture-based learning (LBL) in nursing students.Methods: We searched PubMed, Ovid, Embase, Cochrane, CBM, VIP, CNKI, and Wan Fang databases from inception to 22nd July 2022 to enroll RCTs that compared TBL versus LBL. The studies reporting the performance of nursing students receiving TBL pedagogy compared to those receiving traditional lecture-based learning (LBL) were to be analyzed. Scores of academic or nursing abilities were considered the primary outcome, and the results of nursing competencies, students' engagement with, behaviors, attitudes toward, experience, satisfaction, or perceptions of TBL were considered the secondary outcome. This systematic review was conducted following the guidelines of the Cochrane Reviewer's Handbook and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.Results: A total of 1,009 participants in 10 RCTs were enrolled in this study. Of the 10 RCTs, eight studies investigated undergraduate students, one involved vocational college students, and one enrolled secondary school students. The most reported outcomes were class engagement survey toward TBL (n = 8); students' ability (n = 5), academic knowledge or performance (n = 4); students' experience (n = 4), satisfaction or perceptions of TBL (n = 4).Conclusion: This review suggested that the TBL was an effective pedagogy in improving academic performance and general ability in nursing students. High-quality trials are needed, and standardized outcomes should be used.

14 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
HDHui Deng
Hui Deng
QLQian Lei
Qian Lei
CWChengdi Wang
Chengdi Wang
ZWZhoufeng Wang
Zhoufeng Wang
HCHai Chen
Hai Chen
WLWeimin Li
Weimin Li
Therapeutic responses of non-small cell lung cancer (NSCLC) to epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitors (TKIs) are known to be associated with EGFR mutations. However, a proportion of NSCLCs carrying EGFR mutations still progress on EGFR-TKI underlining the imperfect correlation. Structure-function-based approaches have recently been reported to perform better in retrospectively predicting patient outcomes following EGFR-TKI treatment than exon-based method. Here, we develop a multicolor fluorescence-activated cell sorting (FACS) with an EGFR-TKI-based fluorogenic probe (HX103) to profile active-EGFR in tumors. HX103-based FACS shows an overall agreement with gene mutations of 82.6%, sensitivity of 81.8% and specificity of 83.3% for discriminating EGFR-activating mutations from wild-type in surgical specimens from NSCLC patients. We then translate HX103 to the clinical studies for prediction of EGFR-TKI sensitivity. When integrating computed tomography imaging with HX103-based FACS, we find a high correlation between EGFR-TKI therapy response and probe labeling. These studies demonstrate HX103-based FACS provides a high predictive performance for response to EGFR-TKI, suggesting the potential utility of an EGFR-TKI-based probe in precision medicine trials to stratify NSCLC patients for EGFR-TKI treatment.

2 September 2024 in European Radiology
Verified
Journal Article
Closed access
PDF file
YLYuepeng Li
Yuepeng Li
JDJunyue Deng
Junyue Deng
Xuelei MaXuelei Ma
Xuelei Ma
WLWeimin Li
Weimin Li
ZWZhoufeng Wang
Zhoufeng Wang